Xavier Creative House Earns Continued CyberVadis Gold Rating, Demonstrating Mature Cybersecurity Governance

PHILADELPHIA, Jan. 27, 2026 /PRNewswire/ — Xavier Creative House (XCH), a woman-owned, fully remote healthcare marketing agency serving pharmaceutical, biotech, and medical technology brands, has earned continued CyberVadis Gold status for 2026. XCH achieved a score of 909 out of 1,000, maintaining a Mature cybersecurity posture.

CyberVadis is a globally recognized cybersecurity assessment platform that evaluates organizations across information security governance, technical safeguards, and operational resilience. Sustaining a Gold rating reflects XCH’s ability to maintain effective, well-governed cybersecurity practices as threat landscapes and enterprise requirements continue to evolve.

“Cybersecurity is foundational to trust in healthcare”, said Sunny White, CEO & Founder at Xavier Creative House. “CyberVadis certification reflects our commitment to protecting data, operating with strong governance, and meeting the standards required in highly regulated environments, while enabling responsible innovation across our agency”.

XCH’s CyberVadis performance further reinforces the agency’s enterprise readiness and complements its broader governance credentials, including EcoVadis Platinum status and B Corp Certification, underscoring a sustained commitment to ethical, secure, and responsible business operations.

XCH’s CyberVadis assessment is valid through January 11, 2027.

For more information about Xavier Creative House, visit xaviercreative.com or contact sabram@xaviercreative.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xavier-creative-house-earns-continued-cybervadis-gold-rating-demonstrating-mature-cybersecurity-governance-302670681.html

SOURCE XAVIER CREATIVE

Staff

Recent Posts

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities

LONDON, UK / ACCESS Newswire / January 28, 2026 / THE INFORMATION CONTAINED WITHIN THIS…

1 hour ago

Invitation to Cosmo’s Full Year 2025 Financial Results Webcast on 9 March 2026

Dublin, Ireland--(Newsfile Corp. - January 28, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

2 hours ago

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the…

4 hours ago

REJUVA FRESH® Unveils Three Cutting-Edge Technologies to Empower Providers with a Competitive Edge in 2026

ELLSWORTH, Maine, Jan. 27, 2026 /PRNewswire/ -- At the start of 2026, forward-thinking providers are…

10 hours ago

Revance Executives to Present at IMCAS World Congress 2026

Jeff Bedard and Conor Gallagher to share insights on aesthetic and therapeutic innovationNASHVILLE, Tenn., Jan.…

10 hours ago